Search Within

Jonathan E. Kolitz

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (5)
  2. Conference Paper (1)
Groups
  1. Department of Medicine (6)
  2. Hematologic Malignancies, Division of (6)
  3. Molecular Pharmacology and Chemistry Program Faculty (6)
  4. Sloan Kettering Institute Faculty (6)
  5. Adult Leukemia (3)
  6. Center for Hematologic Malignancies (3)

More Groups

People
  1. Bayard Clarkson (6)
  2. Subhash Gulati (5)
  3. Ellin Berman (3)
  4. Jens Atzodien (3)
  5. Michael Andreeff (3)
  6. Sanford Kempin (3)

More People

Years
  1. 1991 (2)
  2. 1989 (1)
  3. 1988 (3)
Publications
  1. Acta Haematologica (1)
  2. Blood (1)
  3. Experimental Cell Biology (1)
  4. Leukemia and Lymphoma (1)
  5. Oncology (1)
  6. Seminars in Oncology (1)
Publishers
  1. S. Karger AG (3)
  2. American Society of Hematology (1)
  3. Elsevier Inc. (1)
  4. Taylor & Francis Group (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment of Philadelphia chromosome positive (Ph +) chronic myelogenous leukemia in blast crisis and Ph + acute leukemia with high dose cytosine arabinoside (HDARAC)
    Journal Article

    Kempin, S.; Arlin, Z.; Berman, E.; Gee, T.; Mertelsmann, R.; Andreeff, M.; Kolitz, J.; Jhanwar, S.; Myers, J.; Clarkson, B.
    Leukemia and Lymphoma (1991)

    Fulltext@MSK | Save
  • Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia
    Journal Article

    Berman, E.; Heller, G.; Santorsa, J. A.; McKenzie, S.; Gee, T.; Kempin, S.; Gulati, S.; Andreeff, M.; Kolitz, J.; Gabrilove, J.; more...
    Blood (1991)

    Fulltext@MSK | Save
  • Idarubicin in acute leukemia: Results of studies at Memorial Sloan-Kettering Cancer Center
    Conference Paper

    Berman, E.; Raymond, V.; Gee, T.; Kempin, S. J.; Gulati, S.; Andreeff, M.; Kolitz, J.; Gabrilove, J.; Heller, G.; Young, C. W.; more...
    Elsevier Inc. (1989)

    Fulltext@MSK | Save
  • Ewing's sarcoma: Ex vivo sensitivity towards natural and lymphokine-activated killing
    Journal Article

    Atzpodien, J.; Gulati, S. C.; Shimazaki, C.; Bührer, C.; Öz, S.; Kwon, J. H.; Kolitz, J. E.; Clarkson, B. D.
    Oncology (1988)

    Fulltext@MSK | Save
  • Anti-tumor efficacy of interleukin-2-activated killer cells in human neuroblastoma ex vivo
    Journal Article

    Atzpodien, J.; Gulati, S. C.; Kwon, J. H.; Kushner, B. H.; Shimazaki, C.; Bührer, C.; Öz, S.; Kolitz, J. E.; Welte, K.; Clarkson, B. D.
    Experimental Cell Biology (1988)

    Fulltext@MSK | Save
  • Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cells
    Journal Article

    Shimazaki, C.; Atzpodien, J.; Wisniewski, D.; Gulati, S. C.; Kolitz, J. E.; Fried, J.; Clarkson, B. D.
    Acta Haematologica (1988)

    Fulltext@MSK | Save